Cancer |
10 studies |
RR for death = 1.47 (95% CI: 1.01–2.14) |
[39] |
Cardiovascular disease |
13 studies 3027 patients |
OR for critical/mortal patients = 5.19, 95% CI (3.25, 8.29) |
[40] |
16 studies with 4448 patients |
RR for death = 2.25 (95% CI: 1.53, 3.29) |
[41] |
14 studies |
RR for death = 2.25 95% CI (1.60–3.17) |
[39] |
Seven studies with 1576 patients |
OR for severe disease = 3.42 (95% CI: 1.88–6.22) |
[42] |
Cerebrovascular disease |
Six studies with 1527 patients |
RR for severe disease = 3.30, 95% CI (2.03, 5.36) |
[43] |
16 studies with 4448 patients |
RR for death = 2.38 (95% CI: 1.92, 2.96) |
[41] |
Chronic kidney disease |
Nine studies |
RR for death = 3.25 (95% CI: 1.13–9.28) |
[39] |
Congestive heart failure |
Three studies |
RR for death = 2.03 (95% CI: 1.28–3.21) |
[39] |
COPD |
15 studies with 2473 patients |
RR for sever disease = 1.88 (95% CI 1.4–2.4) |
[44] |
Eight studies |
RR for death = 1.33 (95% CI: 0.77–2.31) |
[39] |
Diabetes |
Seven studies with 1576 patients |
OR for severe disease = 2·07 (95% CI 0·88–4·82)a
|
[42] |
13 studies 3027 patients |
OR for critical/mortal patients = 3.68 95% CI (2.68, 5.03) |
[40] |
30 studies with 6452 patients |
RR for death = 2.12 95% CI (1.44, 3.11) |
[45] |
13 studies with 926 patients |
OR for death = 1.75 95% CI (1.31–2.36) |
[46] |
Four studies with 471 patients |
OR for death = 3.21 95% CI (1.82–5.64) |
[47] |
Six studies with 1687 patients |
RR for severe disease = 2.26 (95% CI: 1.47–3.49) |
[48] |
65 studies with 15,794 patients |
RR for death = 2.78 (95% CI: 1.39–5.58) |
[49] |
Six studies with 1527 patients |
RR for severe disease = 2.21, 95% CI (0.88, 5.57)a
|
[43] |
33 studies with 16,003 patients |
OR for death = 1.90 (95% CI: 1.37–2.64) |
[50] |
16 studies |
RR for death = 1.48 (95% CI: 1.02–2.15) |
[39] |
Hypertension |
19 studies with 15,302 cases |
Adjusted OR for death = 1.44, 95% CI (1.24–1.66); I2 = 41.4% |
[51] |
Seven studies with 1576 patients |
OR for severe disease = 2.36 (95% CI: 1.46–3.83) |
[42] |
13 studies 3027 patients |
OR for critical/mortal patients = 2.72, 95% CI (1.60,4.64) |
[40] |
12 studies with 2389 patients |
OR for death = 3.48 (95% CI: 1.72–7.08) |
[52] |
Three studies with 419 patients |
OR for death = 3.36 (95% CI: 1.96–5.7) |
[53] |
65 studies with 15,794 patients |
RR for death = 2.39 (95% CI 1.54–3.73) |
[49] |
six studies with 1527 patients |
RR for severe disease = 2.03 95% CI (1.54, 2.68) |
[43] |
30 studies with 6560 patients |
RR for death = 2.21 (95% CI: 1.74, 2.81) |
[54] |
13 studies |
RR for death = 1.82 (95% CI: 1.43–2.32) |
[39] |
Obesity |
Six studies with 26,507 patients |
OR for death = 3.68 95% CI (1.54–8.83) |
[55] |
Respiratory system |
Seven studies with 1576 patients |
OR for severe disease = 2.46 (95% CI: 1.76–3.44) |
[42] |
13 studies 3027 patients |
OR for critical/mortal patients = 5.15, 95% CI (2.51, 10.57) |
[40] |